For instance, humans with the UGT1A1*28 Gilbert’s polymorphism that causes reduced levels of the UGT1A1 enzyme and increased plasma bilirubin levels in the 18–50 μM range [46,47], have been shown to have decreased incidence of cardiovascular disease [48,49]. Here, UGT1A1 is linked to cardiovascular disorder.